Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
this is probably why delay of 10K 🤔 NO WORRIES HERE GO RNVA 🤑 get out all the bad apples 😎🚀🚀🚀🚀🚀
https://www.sec.gov/news/press-release/2024-51
Yesterdays Darkpool
Short Interest 2,409,523 shares - source: FINRA
Short Interest Ratio 0.07 Days to Cover
Off-Exchange Short Volume 5,323,350 shares - source: FINRA (inc. Dark Pool volume)
Off-Exchange Short Volume Ratio 44.68 % - source: FINRA (inc. Dark Pool volume)
Finpedia Article Rennova Health
what if ceo sold JAMESTOWN and uses that money to BUY the rest of the shares BACK from RNVA 🤔🤑🤑🤑🤑😉
IM SMELLING SOME KINDA BUYOUT
SOMETHING IS HAPPENING BEHIND CLOSE DOORS 🤑🤑🤑🤑🤑🤑🤑🤑🤑🤑🤑🤑
GO RNVA😉😎
could there be a potential BUYOUT 🤑🤔
Yesterday Darkpool
Short Interest 2,409,523 shares - source: FINRA
Short Interest Ratio 0.04 Days to Cover
Off-Exchange Short Volume 4,134,994 shares - source: FINRA (inc. Dark Pool volume)
Off-Exchange Short Volume Ratio 12.02 % - source: FINRA (inc. Dark Pool volume)
Finpedia Article Rennova Health
Fridays Darkpool
Short Interest 2,409,523 shares - source: FINRA
Short Interest Ratio 0.02 Days to Cover
Off-Exchange Short Volume 20,078,152 shares - source: FINRA (inc. Dark Pool volume)
Off-Exchange Short Volume Ratio 33.90 % - source: FINRA (inc. Dark Pool volume)
Finpedia Article Rennova Health
Today'sDarkpool
Short Interest 2,409,523 shares - source: FINRA
Short Interest Ratio 0.04 Days to Cover
Off-Exchange Short Volume 400,000 shares - source: FINRA (inc. Dark Pool volume)
Off-Exchange Short Volume Ratio 8.57 % - source: FINRA (inc. Dark Pool volume)
Finpedia Article Rennova Health
Yesterdays Darkpool
Short Interest 2,934,147 shares - source: FINRA
Short Interest Ratio 0.05 Days to Cover
Off-Exchange Short Volume 27,213,666 shares - source: FINRA (inc. Dark Pool volume)
Off-Exchange Short Volume Ratio 20.33 % - source: FINRA (inc. Dark Pool volume)
Finpedia Article Rennova Health
man shut up and tell your BOSS LAGAN hurry up soon and RUN this tell GOON to tell him to since you guys are paid bashers so ceo can ACCUMULATE 😉🤑🤑🤑🤑🤑🤑🤑🤑🤑
hey i think JT and Goon are the ones here helping CEO accumulate these shares 🤣😉🤑🤑🤑🤑🤑🤑🤑🤑🤑
Hey SABBIE was a crook on the books they cant fool me its a dirty game my friends but somebody has to do it 😉🤑
GO RNVA
who remembers when the ASK was 2billon now only a couple hundred milly on the ASK at 0001 soon will be the same for 0002s 😉🤑
GOOD LUCK BEARS 🤣🤑🤑🤑🤑🤑
also every day over 100MILLION Accumulation what if its ceo BUYING more shares before 10k is released also remember 10Q is due May 15th
🤑🤑🤑🤑🤑🤑🤑🤑🤑🤑
remember ceo is majority shareholder 🤑🤑🤑🤑🤑🤑🤑🤑🤑🤑🤑🤑🤑🤑🤑🤑
No worries here but BEARS will make plenty 🤣
THEY ARE COMING FOR YOU BEAR 😉🤑🤑🤑 NO WORRIES HERE GO RNVA
P.S FIX YOUR NUMBERS NO TRILLION HERE GOOD LUCK BEAR 🐻
only 27million SHORTED over 100MILLION ACCUMULATED again 🤣🤣🤣😉🤑🤑🤑🤑
Good luck BEARS 🐻🤣🤣
honestly if revenues wasn't improving or if debt wasn't being paid and there wasn't a 400 billion shares buy back then I would worry but with all the good happening with RNVA NO WORRIES HERE 😉🤑🤑🤑🤑🤑🤑🤑
they can manipulate all they want they can STACK the ASK is not going to change what is coming 🤑🤑🤑🤑🤑🤑🤑🤑🤑 i would worry if the ASK was 2BILLION again 🤣 not happening GO RNVA 😉
No REVERSE SPLIT FACTS 😉🤑
Lagan stated that there were approximately two hundred and fifty billion shares authorized meaning that there was no need for a reverse split for the foreseeable future. He confirmed that the Company currently had no plans to complete a reverse split.
To hear Seamus Lagan’s entire interview, follow the link to the podcast here:
https://audioboom.com/posts/8157101-rennova-health-inc-provides-update-to-the-stock-day-podcast.
We appreciate the support of our shareholders and look forward to increasing shareholder value in 2024.
I truly believe we will see ceo delivering shareholder value in 2024 🤑
100milly on the ASK AINT SHIT 🤑🤑🤑🤑🤑
GO RNVA 😉
yupYesterdays Darkpool
Short Interest 2,934,147 shares - source: FINRA
Short Interest Ratio 0.05 Days to Cover
Off-Exchange Short Volume 140,205,372
shares - source: FINRA (inc. Dark Pool volume)
Off-Exchange Short Volume Ratio 60.96 % - source: FINRA (inc. Dark Pool volume)
Finpedia Article Rennova Health
Yesterdays Darkpool
Short Interest 2,934,147 shares - source: FINRA
Short Interest Ratio 0.05 Days to Cover
Off-Exchange Short Volume 140,205,372
shares - source: FINRA (inc. Dark Pool volume)
Off-Exchange Short Volume Ratio 60.96 % - source: FINRA (inc. Dark Pool volume)
Finpedia Article Rennova Health
Fridays Darkpool
Short Interest 2,934,147 shares - source: FINRA
Short Interest Ratio 0.05 Days to Cover
Off-Exchange Short Volume 17,814,499 shares - source: FINRA (inc. Dark Pool volume)
Off-Exchange Short Volume Ratio 66.88 % - source: FINRA (inc. Dark Pool volume)
Finpedia Article Rennova Health
yup BEARS BEEN STATING THIS FOR MONTHS ON END THERE WAS NO PRE-14C RITE BEAR LOL LOL LIAR hey RNVA May 23 bro get over it there was no PRE-14C FILED about R/S by the SEC that is not true why did you say it was released? VERY MISLEADING sorry ceo has done a great job.
You been misleading shareholders from day one and even lying about Pre-14C fillings for R/Ss everything has been a total lie to discourage shareholders all you do is try to cause worry and doubt many of us that have been here a year + have been hearing your violin the whole time bear we all know you are a paid bear yours days are numbered 🐻
yup ok you are EXTREMELY BEARISH because you got BURNT in the past FACTS thanks for the heads up plain and simple lol good luck my friend
totally different circumstances in RNVA
You been bearish from day one bro cant fool anyone anymore 🐻
P.s i bet you never even had shares i bet you been a naked short this whole time time to pay up soon
Fridays Darkpool
Short Interest 2,934,147 shares - source: FINRA
Short Interest Ratio 0.05 Days to Cover
Off-Exchange Short Volume 17,814,499 shares - source: FINRA (inc. Dark Pool volume)
Off-Exchange Short Volume Ratio 66.88 % - source: FINRA (inc. Dark Pool volume)
Finpedia Article Rennova Health
you been SOLD LOL why still bother lol GO RNVA BEARS ARE SCREWED and they know it we dont need your advice my friend good luck all bears Credibility is gone ceo has done a great job
I remember
RNVA https://www.globenewswire.com/news-release/2023/08/14/2724557/0/en/RENNOVA-HEALTH-INC-ANNOUNCES-THE-OPENING-OF-ITS-FIRST-ALCOHOL-AND-DRUG-TREATMENT-FACILITY.html
https://www.globenewswire.com/news-release/2023/06/13/2687244/0/en/RENNOVA-HEALTH-INC-ANNOUNCES-THE-EXPANSION-OF-SERVICES-AT-ITS-BIG-SOUTH-FORK-MEDICAL-CENTER-HOSPITAL-TO-INCLUDE-SWING-BEDS.html
https://ir.rennovahealth.com/press-releases/detail/335/rennova-health-inc-provides-update-after-filing-2022
https://audioboom.com/posts/8251354-rennova-health-rnva-is-featured-on-the-stock-day-podcast
i remember
RNVA https://www.globenewswire.com/news-release/2023/08/21/2728714/0/en/RENNOVA-HEALTH-INC-PROVIDES-UPDATE-AFTER-FILING-2023-SECOND-QUARTER-FINANCIAL-STATEMENTS.html
Davis then mentioned the fast approaching year end and suggested that the Company could be leaving 2023 with annualized revenues in the $25-30 million range and be profitable. He asked Lagan how he intended to deliver continued growth and where he saw the Company a year from now.
Lagan responded that the current operations plus the behavioral health business should give the Company an annualized run rate of $25-30 million by year end. He went on to remind Davis that there were still some items to be fixed from previous more difficult days but explained the intention to formulate a plan before year end to duplicate the current model in the Jamestown facility in 2024, and stated that if that was successful it would be possible to leave 2024 with annualized revenues of $50-60 million. He confirmed his belief that this was achievable.
Davis ended the interview by asking Lagan what message he would like the Company’s shareholders to take away from the interview. Lagan responded by saying that he believed the Company was now delivering what it had hoped to deliver from work done over the past couple of years and stated a belief that there will be continued success and growth over the next couple of years.
GO RNVA
“The SEC alleges that Sabby and Mintz attempted to game the system and make an illegal profit,” said Carolyn Welshhans, Associate Director of the SEC’s Division of Enforcement. “When someone uses naked shorts or other manipulative practices to cheat the market and investors, the SEC will ensure that they are held accountable.”
P.s time to pay up fools 😉 this why the BEARS are so relentless BEARS are going lose millions and will go rite in our BANKS 🤑
The expiration of such a large number of warrants significantly reduces potential dilution to common shareholders,” said Seamus Lagan, CEO of Rennova, “and extending a number of warrants as agreed, preserves the Company’s ability to access additional capital through warrant exercises if market conditions permit.”
LOOK BEARS ARE IN DISBELIEF 🤣🤣🤣 DONT WORRY CUBBIES BEARS THERES MORE COMING PAID BASHERS TIME TO PAY UP SOON 😉🤑
No REVERSE SPLIT FACTS 😉🤑
Lagan stated that there were approximately two hundred and fifty billion shares authorized meaning that there was no need for a reverse split for the foreseeable future. He confirmed that the Company currently had no plans to complete a reverse split.
To hear Seamus Lagan’s entire interview, follow the link to the podcast here:
https://audioboom.com/posts/8157101-rennova-health-inc-provides-update-to-the-stock-day-podcast.
We appreciate the support of our shareholders and look forward to increasing shareholder value in 2024.
I truly believe we will see ceo delivering shareholder value in 2024 🤑
RNVA Margins 🤑 FACTS 😂😉
Gross margin is 63.10%, with operating and profit margins of 17.96% and 11.66%.
Gross Margin 63.10%
Operating Margin 17.96%
Pretax Margin 14.83%
Profit Margin 11.66%
EBITDA Margin 24.45%
EBIT Margin 22.63%
FCF Margin 18.36%
Item 1.01 Entry Into a Material Definitive Agreement
On March 20, 2024, Rennova Health, Inc. (the “Company”) and certain institutional holders agreed that, with respect to Series B Warrants (originally issued on March 21, 2017), to acquire 101,350,000,000 shares of common stock, the termination date of such warrants would be extended from March 21, 2024 to December 31, 2025; provided, that (subject to the Company then having an effective registration statement covering the applicable number of shares), if Series B Warrants to acquire the following number of shares of common stock are not exercised in the respective periods below (each, an “Exercise Condition”), the termination date of all of the Series B Warrants shall instead be the date the first such Exercise Condition is not satisfied:
From March 21, 2024 to April 15, 2024 1,350,000,000 shares
From April 16, 2024 to August 30, 2024 2,500,000,000 shares
From August 31, 2024 to December 27, 2024 4,000,000,000 shares
From December 28, 2024 to April 24, 2025 4,000,000,000 shares
From April 25, 2025 to August 29, 2025 4,000,000,000 shares
Piotroski F-Score for Rennova Health, Inc.
In 2000, Joseph Piotroski published a paper titled "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers." This paper described a method of using data from a company's financial reports to help predict future performance.
The Piotroski F-Score, as it is known, is a 9-point discrete score, where 9 is the best, that ranks companies based on a number of financial factors. To calculate the score, we compare nine factors from the two most recent annual reports. If the change in the factor is "good", then we add one to the score. If the change in the factor is "not good", then we add zero. The following explanations are quoted from the paper.
F-Score
8 /9
No BANKRUPTCY HERE BEARS KEEP DREAMING JUST LIKE THE R/S THEORY 🐻🤣🤣🤣🤣
Significant net revenue growth. Growth in net revenues in the third quarter 2023 compared to the prior year’s quarter was 25% reflecting increased patient activity at the hospital and higher reimbursement rates. The Company reported net revenues of approximately $14.8 million for the nine-months ending September 30, 2023 and, therefore, expects to report a significant increase in full year net revenues compared to approximately $13.0 million in net revenues that were reported for 2022.
Debt reduction. Debt from year-end 2022 to September 30, 2023 was reduced from $14.5 million to $11.6 million—a reduction of $2.9 million through debt pay-downs and/or negotiated settlements.
Debt restructuring. We successfully negotiated a debt restructuring with a key institutional lender holding $8.2 million of secured debt in October 2023 to extend the maturity to December 2025 and implement other modifications which waived historical defaults thereby saving default interest in future periods. This restructuring will further improve our balance sheet at December 31, 2023.
Rennova Health had revenue of $20.30M in the twelve months ending September 30, 2023, with 113.44% growth year-over-year. Revenue in the quarter ending September 30, 2023 was $3.54M with 25.20% year-over-year growth. In the year 2022, Rennova Health had annual revenue of $13.04M with 304.36% growth.
🤑🤑🤑🤑🤑🤑🤑🤑🤑
P.S i cant wait to see 10-k remember 10Q is due 5/15 🤑🤑🤑🤑🤑🤑🤑 no worries BEARS 🤣🤣😉
About
Currently the CEO of Rennova Health, Inc.
More information at www.rennovahealth.com
Restructured Medytox Solutions, Inc. in mid 2011 and oversaw the growth from less than $1M of sales per year to approximately $57M of reported sales in 2014. Completed merger with CollabRx, Inc. in 2015 to create Nasdaq listed Rennova Health, Inc. (RNVA) in November 2015. Redirected business model from diagnostics to rural hospital development and acquisition in 2017 after significant disruption in the diagnostics sector.
Over 20 years’ experience in the development, restructuring, acquisition and management of startup and small companies in various sectors from alternative energy, oil and gas production and exploration, mining and healthcare. Provides services for both private and public companies. Has an extensive network of legal, accounting and other professional advisers that can be relied on to assist when required. Has numerous funding sources in different sectors to approach if required for qualifying projects. Has secured and structured millions of dollars in funding for various projects, including in excess of $30M in equity funding and approximately $20M of debt in 2015 and 2016 and a further $20M of investment in 2017. Main focus is acquisition and mergers of synergistic business with an emphasis on revenue and a sustainable business model to create long term value.
NOBODY LISTENS TO THE BEARS CEO KNOWS EXACTLY WHAT HE IS DOING THESE BEARS CANT EVEN SLEEP AT NIGHT 😉
WATCH AND LEARN LOOK AT CEO BACK ROUND AND LOOK AT THE BEARS 🐻 LOL 🤣 FOOLS SHOULD HAVE NEVER OVER SHORTED AND BET AGAINST RNVA FOOLS 😉🤑
About
Currently the CEO of Rennova Health, Inc.
More information at www.rennovahealth.com
Restructured Medytox Solutions, Inc. in mid 2011 and oversaw the growth from less than $1M of sales per year to approximately $57M of reported sales in 2014. Completed merger with CollabRx, Inc. in 2015 to create Nasdaq listed Rennova Health, Inc. (RNVA) in November 2015. Redirected business model from diagnostics to rural hospital development and acquisition in 2017 after significant disruption in the diagnostics sector.
Over 20 years’ experience in the development, restructuring, acquisition and management of startup and small companies in various sectors from alternative energy, oil and gas production and exploration, mining and healthcare. Provides services for both private and public companies. Has an extensive network of legal, accounting and other professional advisers that can be relied on to assist when required. Has numerous funding sources in different sectors to approach if required for qualifying projects. Has secured and structured millions of dollars in funding for various projects, including in excess of $30M in equity funding and approximately $20M of debt in 2015 and 2016 and a further $20M of investment in 2017. Main focus is acquisition and mergers of synergistic business with an emphasis on revenue and a sustainable business model to create long term value.
NOBODY LISTENS TO THE BEARS CEO KNOWS EXACTLY WHAT HE IS DOING THESE BEARS CANT EVEN SLEEP AT NIGHT 😉
WATCH AND LEARN LOOK AT CEO BACK ROUND AND LOOK AT THE BEARS 🐻 LOL 🤣 FOOLS SHOULD HAVE NEVER OVER SHORTED AND BET AGAINST RNVA FOOLS 😉🤑
Yesterdays Darkpool
Short Interest 2,934,147 shares - source: FINRA
Short Interest Ratio 0.14 Days to Cover
Off-Exchange Short Volume 28,711,290 shares - source: FINRA (inc. Dark Pool volume)
Off-Exchange Short Volume Ratio 21.19 % - source: FINRA (inc. Dark Pool volume)
Finpedia Article Rennova Health